October 16th, Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SH) stated on the investor interaction platform that the company's crystalline intraocular lens (PR) product is still in the approval process and has not yet been certified for listing. The business plan cannot be disclosed conveniently. The company will continue to fully leverage its own technological and academic promotion advantages, as well as the synergies of various business lines, to expand brand influence, enhance recognition among doctors, patients, and consumers, constantly consolidate, and increase market share.